Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Eloxx Pharmaceuticals Q2 EPS $(1.96) Misses $(1.54) Estimate

Author: Happy Mohamed | August 14, 2023 08:43am

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(1.96) per share which missed the analyst consensus estimate of $(1.54) by 27.27 percent. This is a 1533.33 percent decrease over losses of $(0.12) per share from the same period last year.

Posted In: ELOX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist